Sp737
PANEL DISCUSSION
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
This session will provide attendees with an overview of physician advocacy, how it impacts the GI community and how to get involved. We will discuss AGA advocacy priorities, a model for removing barriers to high-value care in inflammatory bowel disease and GI, and how to most effectively engage in collaborative advocacy on behalf of the GI community.
This session will provide attendees with an overview of physician advocacy, how it impacts the GI community and how to get involved. We will discuss AGA advocacy priorities, a model for removing barriers to high-value care in inflammatory bowel disease and GI, and how to most effectively engage in collaborative advocacy on behalf of the GI community.
Presenters
University of Washington
Duke University School of Medicine
Tracks
Related Products
ADHERENCE TO AGA GUIDELINES FOR GASTROINTESTINAL EVALUATION OF IRON DEFICIENCY ANEMIA
INTRODUCTION: A number of medications have been implicated as primary risk factors for microscopic colitis (MC) and guidelines recommend discontinuation of these medications as part of MC management…
Q&A
This session is designed to demonstrate successful quality improvement in practices and across institutions with the focus on and meaningful real world implementation across a range of GI conditions…
NOVEL DIAGNOSTIC TOOLS AND METRICS FOR GERD: READY FOR PRIMETIME?
This session will provide an overview of the recent advances in diagnostic approaches to GERD, expansion in types and roles of diagnostic tools including ambulatory reflux monitoring, esophageal manometry, FLIP and MI in regards to GERD, and updates in guidelines and best practice advice…
AGA Getting Off the Menu and Back at the Table: Challenges for GI in Advocacy
This session will provide attendees with an overview of physician advocacy, how it impacts the GI community and how to get involved…
